Powder: -20°C for 3 years | In solvent: -80°C for 1 year
R 59-022 is a 5-HTR antagonist and activates protein kinase C (PKC). R 59-022 is a diacylglycerol kinase inhibitor (IC50=2.8 μM). R 59-022 potentiates thrombin-induced diacylglycerol production in platelets and inhibits phosphatidic acid production in neutrophils.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 93.00 | |
5 mg | 35 days | $ 225.00 | |
10 mg | 35 days | $ 393.00 | |
50 mg | 35 days | $ 1,670.00 |
Description | R 59-022 is a 5-HTR antagonist and activates protein kinase C (PKC). R 59-022 is a diacylglycerol kinase inhibitor (IC50=2.8 μM). R 59-022 potentiates thrombin-induced diacylglycerol production in platelets and inhibits phosphatidic acid production in neutrophils. |
Targets&IC50 | DGK:2.8 μM |
In vitro | R 59-022 is able to interrupt thrombin-induced inositol lipid cycling at the level of diacylglycerol and leads to an elevation of protein kinase C activity, in the intact platelet. R 59-022 blocks entry of EBOV pseudotypes in a concentration-dependent manner (IC50: ~5 μM). R 59-022, an inhibitor of filovirus entry, prevents the macropinocytic uptake of filoviral particles, inhibits entry mediated by multiple filovirus GPs, and blocks replicative EBOV growth. R 59-022 dose-dependent decreases in entry by the VLPs harboring the EBOV GP (IC50: ~2 μM). R 59-022 (10 μM) potentiates aggregation, but not shape change induced by sub-maximal concentrations of thrombin. R59022 (10 μM) had no significant effect on the dose-response curve for the mobilization of intracellular Ca2+ by thrombin in either the presence or the absence of extracellular Ca2+. R 59-022 (2-12 μM; 1 hour) can inhibit EBOV GP-mediated entry in multiple cell types. R 59-022 (5 μM; 30 minutes) blocks macropinocytosis in vero cells[1][2][5]. |
Synonyms | Diacylglycerol kinase inhibitor I, DKGI-I |
Molecular Weight | 459.58 |
Formula | C27H26FN3OS |
CAS No. | 93076-89-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
R 59-022 93076-89-2 Others R 59022 Diacylglycerol kinase inhibitor I DKGI-I R 59 022 inhibitor inhibit